The benefit of adjunctive intravenous thrombolysis before mechanical thrombectomy (MT) in patients with acute ischemic stroke remains an issue of strong debate. Hrvoje Budincevic, MD, PhD, FESO, Sveti Duh University Hospital, Zagreb, Croatia, discusses the current use of thrombolysis in clinical practice. Current guidelines recommend the use of intravenous thrombolysis before mechanical thrombectomy, and randomized clinical trials comparing bridging thrombolysis (intravenous thrombolysis + MT) versus direct MT in acute ischemic stroke were unable to show the non-inferiority of direct MT. This interview took place at the 17th World Congress on Controversies in Neurology (CONy) in Dubrovnik, Croatia.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Speaker’s Fees for: Bayer, Berlin Chemie Menarini, Boehringer Ingelheim, and Pfizer